BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 8477872)

  • 1. Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism.
    Brichard SM; Henquin JC; Girard J
    Diabetologia; 1993 Apr; 36(4):292-8. PubMed ID: 8477872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes, and on glucose transporter GLUT2.
    Brichard SM; Desbuquois B; Girard J
    Mol Cell Endocrinol; 1993 Feb; 91(1-2):91-7. PubMed ID: 8472858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats.
    Becker DJ; Reul B; Ozcelikay AT; Buchet JP; Henquin JC; Brichard SM
    Diabetologia; 1996 Jan; 39(1):3-11. PubMed ID: 8720597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinaemia and increased by hyperglycaemia in liver of diabetic rats.
    Burcelin R; Eddouks M; Kande J; Assan R; Girard J
    Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):675-9. PubMed ID: 1463468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats.
    Valera A; Rodriguez-Gil JE; Bosch F
    J Clin Invest; 1993 Jul; 92(1):4-11. PubMed ID: 8100835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
    Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
    Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like actions of tungstate in diabetic rats. Normalization of hepatic glucose metabolism.
    Barberà A; Rodríguez-Gil JE; Guinovart JJ
    J Biol Chem; 1994 Aug; 269(31):20047-53. PubMed ID: 8051090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of diabetic alterations by glucokinase.
    Ferre T; Pujol A; Riu E; Bosch F; Valera A
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7225-30. PubMed ID: 8692973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered levels of mRNA encoding enzymes of hepatic glucose metabolism in septic rats.
    Chang CK; Moskal SF; Srivenugopal KS; Schumer W
    Circ Shock; 1993 Sep; 41(1):35-9. PubMed ID: 8403244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo.
    Marzban L; Rahimian R; Brownsey RW; McNeill JH
    Endocrinology; 2002 Dec; 143(12):4636-45. PubMed ID: 12446591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fisetin improves glucose homeostasis through the inhibition of gluconeogenic enzymes in hepatic tissues of streptozotocin induced diabetic rats.
    Prasath GS; Pillai SI; Subramanian SP
    Eur J Pharmacol; 2014 Oct; 740():248-54. PubMed ID: 25064342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of gene expression by insulin is differentially impaired in the liver of the genetically obese-hyperglycemic Wistar fatty rat.
    Noguchi T; Matsuda T; Tomari Y; Yamada K; Imai E; Wang Z; Ikeda H; Tanaka T
    FEBS Lett; 1993 Aug; 328(1-2):145-8. PubMed ID: 7688320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression.
    Hofmann CA; Edwards CW; Hillman RM; Colca JR
    Endocrinology; 1992 Feb; 130(2):735-40. PubMed ID: 1733721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats.
    Chan P; Wong KL; Liu IM; Tzeng TF; Yang TL; Cheng JT
    J Hypertens; 2003 Apr; 21(4):761-9. PubMed ID: 12658023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats.
    Burcelin R; Printz RL; Kande J; Assan R; Granner DK; Girard J
    Am J Physiol; 1993 Sep; 265(3 Pt 1):E392-401. PubMed ID: 8214048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gluconeogenic-glycolytic capacities and metabolic zonation in liver of rats with streptozotocin, non-ketotic as compared to alloxan, ketotic diabetes.
    Miethke H; Wittig B; Nath A; Jungermann K
    Histochemistry; 1986; 85(6):483-9. PubMed ID: 3023262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression of regulatory enzymes of glycolysis/gluconeogenesis in regenerating rat liver.
    Rosa JL; Bartrons R; Tauler A
    Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):113-6. PubMed ID: 1329724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of starvation on gene expression of regulatory enzymes of glycolysis/gluconeogenesis in genetically obese (fa/fa) Zucker rats.
    Pérez JX; Manzano A; Tauler A; Bartrons R
    Int J Obes Relat Metab Disord; 1998 Jul; 22(7):667-72. PubMed ID: 9705027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of diabetic alterations in transgenic mice overexpressing Myc in the liver.
    Riu E; Bosch F; Valera A
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2198-202. PubMed ID: 8700908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats.
    Liu IM; Hsu FL; Chen CF; Cheng JT
    Br J Pharmacol; 2000 Feb; 129(4):631-6. PubMed ID: 10683186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.